Chronic venous ulcers (CVU) of the lower limbs (LL) are common and cause psychological changes and significant social impact, as they make the patient susceptible to pain, absence from work and social bonds. Some materials are suggested as dressings for the treatment of CVU, but they are expensive and are generally not available for use in public health services. To evaluate the efficacy of the treatment for lower limbs (LL) chronic venous ulcer (CVU) using bacterial cellulose (BC), gel and multi-perforated film associated. A randomized controlled clinical-intervention study was performed among participants with LL CVU, divided into two groups: experimental (EG), treated with BC wound dressing and control (CG), treated with a cellulose acetate mesh impregnated with essential fatty acids (Rayon®). The participants were followed for 180 days, evaluated according to the MEASURE methodology. Thirty-nine patients were treated, 20 from the EG and 19 from the CG. In both groups, the wound area decreased significantly (p < 0.001), the healing rate was similar to the CG. The mean number of dressing changes in the SG was 18.33 ± 11.78, while in the CG it was 55.24 ± 25.81, p < 0.001. The healing dressing of bacterial cellulose, gel and associated film, when stimulating the epithelization of the lesions, showed a significant reduction in the initial area, with a percentage of cure similar to the Rayon® coverage. In addition to requiring less direct manipulation of ulcers.

The poor healing of diabetic wounds is characterized by prolonged inflammation and decreased collagen deposition. Diabetic patients exhibit changes in the plasma concentrations of pro-inflammatory cytokines, and the role of specific dressings may have an impact on healing. This study aims to evaluate the effects of a combined treatment comprising a bacterial cellulose dressing and melatonin application on the regulation and expression of inflammatory cytokines, VEGF, PCNA, and collagen in the healing of cutaneous wounds of diabetic rats. Pro-inflammatory cytokines, including IL-6, TNF-α, and VEGF, along with PCNA and type I and III collagen, were evaluated after 14 days. Immunohistochemistry showed decreased levels of IL-6, TNF-α, and VEGF, along with an increased expression of PCNA and type I collagen, in the groups treated exclusively with melatonin and bacterial cellulose associated with melatonin compared to the control and the commercial healing agent. It was concluded that treating the skin lesions of diabetic animals supplemented with melatonin using a bacterial cellulose-based dressing has positive effects in regulating the expression of inflammatory cytokines, vascular endothelial growth factor, and collagen, showing that this association could be a viable therapy approach in wound healing.

Wound management remains a significant global healthcare challenge, particularly due to chronic wounds that resist healing and impose economic and social burdens. Bacterial cellulose (BC), owing to its biocompatibility, high purity and moisture-handling capabilities, has gained attention as a wound dressing material. This study provides a comparative evaluation of a commercial BC film (Membracel^®), a non-commercial BC from POLISA^® (BCP) and an experimental BC from SENAI CIMATEC (BCC), all produced via static fermentation using distinct culture conditions. Comprehensive characterization included scanning electron microscopy, X-ray diffraction, Fourier transform infrared spectroscopy, thermogravimetric analysis, solid-state ¹³C NMR, water interaction assessments, porosity and vapor permeability measurements, optical and mechanical testing and in vitro stability in simulated wound fluid. The three BC films exhibited markedly different structural and functional profiles. BCC displayed the highest crystallinity (78.7%), thermal stability and vapor permeability, indicating suitability for wounds with high exudate. BCP showed the greatest tensile strength (46.2 MPa) and flexibility, suggesting utility where mechanical robustness is required. Membracel^® exhibited lower crystallinity and vapor permeability, appropriate for low-exudate wounds. All samples remained dimensionally stable in simulated wound fluid. These findings highlight clear correlations between the physicochemical properties of BC-based dressings and their potential clinical applications, supporting the development of tailored wound care solutions based on wound type and moisture management requirements.

The aim of this study is to evaluate if a gel of bacterial cellulose gel can revert the loss of anal resting pressure after anorectum sphincter injury in rat model, elected as a model to simulate fecal incontinence. Thirty-nine animals were equally divided into three groups: Control (CG), Sphincter injury plus Saline injection (SG) and Sphincter injury plus Bacterial Cellulose Gel injection (BCG). Anal pressure at rest was assessed for all animal in the three groups using anorectum manometry. Saline and Gel groups were subject to anorectum sphincter injury to reduce the anal pressure at rest. Fifteen days later Saline or Gel was injected into the anorectum, according to their groups. Sixty days later first manometry, the anorectum of all animals were removed and processed histologically. The CG group showed maintenance of their mean anorectal resting pressure levels; SG presented a fall in their mean anorectal resting pressure. The BCG presented a significant elevation of the mean anorectal resting pressure levels, surpassing the pressure of CG. The gel of bacterial cellulose remained at the injection site and was neovascularized, colonized by fibroblasts and dense conjunctive tissue. Those data suggest that BC can be used as a future filling agent treatment for fecal incontinence in clinical trial protocols.

To describe the effects of melatonin associated with bacterial cellulose-based hydrogel on healing of skin wounds in diabetic rats.

Chronic venous insufficiency is common all over the world. It is often related to lower limb varicose veins. Surgical treatment is necessary in most cases but the management of the operative wounds remains a challenge. Nowadays, there is no consensus on which is the ideal dressing for covering operative wounds, but features such as low cost, hypoallergenicity, and good adherence are expected. In this study, a material that meets all these features, the bacterial cellulose film (BCF), was evaluated in patients who underwent varicose vein surgery. A randomized, prospective clinical trial was carried out at the Angiology and Vascular Surgery Department of the Hospital das Clínicas/EBSERH - UFPE, from May 2023 to September 2024. The study included 55 patients who underwent varicose vein surgery, divided in two groups: an experimental group, which used a BCF to cover microincisions, and a control group. which used microporous tape. Between postoperative days 4 and 6, patients were assessed for pain, itching, and wound appearance using the Southampton Wound Assessment Scale. The groups were homogeneous in all demographic data, presence of comorbidities, and Clinical-Etiology-Anatomy-Pathophysiology Clinical classification. Pain on removal was more common in the control group with a mean scale score of 3.46 ± 3.26 compared with 0.63 ± 1.38 (P < .001). There was no statistical difference between the groups in itching and wound healing. BCF showed healing results comparable with microporous tape, with the advantage of generating less pain on removal.